DaVita HealthCare Partners is a medical care facilities business based in the US. DaVita HealthCare Partners shares (DVA) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $156.98 – a decrease of 0.19% over the previous week. DaVita HealthCare Partners employs 70,000 staff and has a trailing 12-month revenue of around $12.7 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $156.98 |
|---|---|
| 52-week range | $95.60 - $168.50 |
| 50-day moving average | $157.57 |
| 200-day moving average | $141.83 |
| Wall St. target price | $156.90 |
| PE ratio | 16.944 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $9.11 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $157.41 from 2024-11-18
| 1 week (2024-11-13) | 0.08% |
|---|---|
| 1 month (2024-10-18) | -2.82% |
| 3 months (2024-08-20) | 6.66% |
| 6 months (2024-05-20) | 11.69% |
| 1 year (2023-11-20) | 61.40% |
|---|---|
| 2 years (2022-11-18) | 122.80% |
| 3 years (2021-11-19) | 58.12% |
| 5 years (2019-11-20) | 117.12% |
Valuing DaVita HealthCare Partners stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of DaVita HealthCare Partners's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
DaVita HealthCare Partners's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, DaVita HealthCare Partners shares trade at around 17x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
DaVita HealthCare Partners's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1852. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into DaVita HealthCare Partners's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
DaVita HealthCare Partners's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.7 billion.
The EBITDA is a measure of a DaVita HealthCare Partners's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $12.7 billion |
|---|---|
| Operating margin TTM | 16.28% |
| Gross profit TTM | $3.4 billion |
| Return on assets TTM | 6.94% |
| Return on equity TTM | 44.88% |
| Profit margin | 6.53% |
| Book value | $4.68 |
| Market Capitalization | $12.7 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like DaVita HealthCare Partners.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 20.07
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and DaVita HealthCare Partners's overall score of 20.07 (as at 12/31/2018) is pretty good – landing it in it in the 24th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like DaVita HealthCare Partners is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 2.6/100
DaVita HealthCare Partners's environmental score of 2.6 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that DaVita HealthCare Partners is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 10.68/100
DaVita HealthCare Partners's social score of 10.68 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that DaVita HealthCare Partners is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 7.8/100
DaVita HealthCare Partners's governance score puts it squarely in the 3rd percentile of companies rated in the same sector. That could suggest that DaVita HealthCare Partners is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. DaVita HealthCare Partners scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that DaVita HealthCare Partners has, for the most part, managed to keep its nose clean.
DaVita HealthCare Partners Inc was last rated for ESG on: 2019-01-01.
| Total ESG score | 20.07 |
|---|---|
| Total ESG percentile | 24.1 |
| Environmental score | 2.6 |
| Environmental score percentile | 3 |
| Social score | 10.68 |
| Social score percentile | 3 |
| Governance score | 7.8 |
| Governance score percentile | 3 |
| Level of controversy | 2 |
We're not expecting DaVita HealthCare Partners to pay a dividend over the next 12 months.
DaVita HealthCare Partners's shares were split on a 2:1 basis on 8 September 2013 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your DaVita HealthCare Partners shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for DaVita HealthCare Partners shares which in turn could have impacted DaVita HealthCare Partners's share price.
Over the last 12 months, DaVita HealthCare Partners's shares have ranged in value from as little as $95.6 up to $168.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while DaVita HealthCare Partners's is 0.887. This would suggest that DaVita HealthCare Partners's shares are less volatile than average (for this exchange).
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.